mitomycin has been researched along with Neuroendocrine Tumors in 4 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
Neuroendocrine Tumors: Tumors whose cells possess secretory granules and originate from the neuroectoderm, i.e., the cells of the ectoblast or epiblast that program the neuroendocrine system. Common properties across most neuroendocrine tumors include ectopic hormone production (often via APUD CELLS), the presence of tumor-associated antigens, and isozyme composition.
Excerpt | Relevance | Reference |
---|---|---|
"Measurement of serum pancreastatin levels is an easy and useful method to predict success in patients who undergo HACE plus somatostatin therapy for metastatic neuroendocrine tumors to the liver." | 7.71 | Serum pancreastatin levels predict response to hepatic artery chemoembolization and somatostatin analogue therapy in metastatic neuroendocrine tumors. ( Desai, DC; Jung, SS; Khabiri, H; Martin, EW; O'Dorisio, TM; Schirmer, WJ; Villanueva, V, 2001) |
"The objective of our study was to retrospectively determine the effectiveness of hepatic transarterial chemotherapy using two therapeutic protocols-mitomycin C alone and combined mitomycin C and gemcitabine-on local tumor control and survival rate in patients with liver metastases from neuroendocrine tumors." | 3.75 | Liver metastases of neuroendocrine tumors: treatment with hepatic transarterial chemotherapy using two therapeutic protocols. ( Gruber, T; Hammerstingl, R; Naguib, NN; Nour-Eldin, NE; Vogl, TJ, 2009) |
"Measurement of serum pancreastatin levels is an easy and useful method to predict success in patients who undergo HACE plus somatostatin therapy for metastatic neuroendocrine tumors to the liver." | 3.71 | Serum pancreastatin levels predict response to hepatic artery chemoembolization and somatostatin analogue therapy in metastatic neuroendocrine tumors. ( Desai, DC; Jung, SS; Khabiri, H; Martin, EW; O'Dorisio, TM; Schirmer, WJ; Villanueva, V, 2001) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Barrak, D | 1 |
Desale, S | 1 |
Yoon, JJ | 1 |
Dugan, MM | 1 |
Kodavanti, PP | 1 |
Sampah, ME | 1 |
Sugarbaker, PH | 1 |
Sabourin, JC | 1 |
Vogl, TJ | 1 |
Gruber, T | 1 |
Naguib, NN | 1 |
Hammerstingl, R | 1 |
Nour-Eldin, NE | 1 |
Desai, DC | 1 |
O'Dorisio, TM | 1 |
Schirmer, WJ | 1 |
Jung, SS | 1 |
Khabiri, H | 1 |
Villanueva, V | 1 |
Martin, EW | 1 |
2 reviews available for mitomycin and Neuroendocrine Tumors
Article | Year |
---|---|
Appendiceal tumors with glandular and neuroendocrine features exhibiting peritoneal metastases - Critical evaluation of outcome following cytoreductive surgery with perioperative chemotherapy.
Topics: Adenocarcinoma; Administration, Intravenous; Adult; Aged; Antineoplastic Combined Chemotherapy Proto | 2021 |
[Peritoneal tumor pathology: case n(o) 2: a "sticky" peritoneal tumor].
Topics: Abdominal Pain; Adult; Antineoplastic Agents, Alkylating; Appendectomy; Appendiceal Neoplasms; Combi | 2015 |
2 other studies available for mitomycin and Neuroendocrine Tumors
Article | Year |
---|---|
Liver metastases of neuroendocrine tumors: treatment with hepatic transarterial chemotherapy using two therapeutic protocols.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined C | 2009 |
Serum pancreastatin levels predict response to hepatic artery chemoembolization and somatostatin analogue therapy in metastatic neuroendocrine tumors.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Biomarkers, Tumor; Chemoembolization, Therape | 2001 |